Related Experiment Video

Updated: Jun 10, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

The cardiologist and smoking cessation

Victor Aboyans1, Daniel Thomas, Philippe Lacroix

  • 1Department of Thoracic and Cardiovascular Surgery and Vascular Medicine, Dupuytren University Hospital, Limoges, France. victor.aboyans@unilim.fr

Current Opinion in Cardiology
|July 31, 2010
PubMed

Insights

Smoking cessation significantly benefits cardiovascular disease patients more than other interventions. However, cardiologists show limited interest and commitment to assisting patients with smoking cessation, hindering improved patient survival rates.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Smoking is a major modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality globally.
  • Smoking cessation offers greater benefits in CVD patients than blood pressure or cholesterol management.
  • In-hospital smoking cessation interventions with follow-up are highly cost-effective for improving cardiovascular patient survival.

Purpose of the Study:

  • To review the importance of smoking cessation in cardiovascular disease prevention.
  • To assess cardiologists' current engagement with smoking cessation assistance for their patients.
  • To identify barriers hindering cardiologists' performance in smoking cessation interventions.

Main Methods:

  • Review of existing data and surveys on cardiologists' knowledge, interest, and attitudes towards smoking cessation.
  • Analysis of current practices regarding smoking cessation assistance and referrals in cardiology.

Main Results:

  • Cardiologists demonstrate limited interest and commitment to increasing smoking cessation rates.
  • Many cardiologists do not consider smoking cessation assistance a core part of their practice.
  • A significant number of cardiologists fail to refer smoking patients to specialized cessation centers.

Conclusions:

  • Stronger commitment from cardiologists is essential for effective smoking cessation in cardiovascular prevention.
  • Further research is required to understand and overcome barriers to cardiologists' improved clinical performance in smoking cessation.
Abstract

More Related Videos

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...